⌘K

Home/Filings/4/0001209191-19-021286

4//SEC Filing

Apelian David 4

Accession 0001209191-19-021286

CIK 0001305253other

View on SEC.gov Company Profile

Filed

Mar 25, 8:00 PM ET

Accepted

Mar 26, 10:22 AM ET

Size

9.1 KB

Accession

0001209191-19-021286

Insider Transaction Report

Form 4

Period: 2019-03-21

Eiger BioPharmaceuticals, Inc.EIGR

Director

Transactions

Award
Stock Option ( Right to Buy)
2019-03-21+110,500→ 110,500 total
Exercise: $14.31Exp: 2029-03-20→ Common Stock (110,500 underlying)

Footnotes (1)

[F1]The option vests in equal monthly installments over 48 months measured from March 21, 2019 subject to Reporting Person's continuous service status as of each such date.

Documents

2 files

Issuer

Eiger BioPharmaceuticals, Inc.

CIK 0001305253

Entity typeother

Related Parties

1

filerCIK 0001546842

Filing Metadata

Form type: 4
Filed: Mar 25, 8:00 PM ET
Accepted: Mar 26, 10:22 AM ET
Size: 9.1 KB

View on SEC.gov